RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery system, today ...

Tinnitus affects up to 43% of people depending on definitions and populations studied. This phantom perception of sound can ...

Ractigen Therapeutics, a clinical-stage Pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I ...

A new study highlights a groundbreaking development for chronic low back pain caused by degenerative disc disease (DDD).

A new method of scanning lungs led by a team at Newcastle University, UK, is able to show in real time how air moves in and ...